Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glial Tumor of Brain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03401866
What this trial is testing

Multi-site Validation and Application of a Consensus DSC-MRI Protocol

Who this might be right for
Glioblastoma MultiformeGliosarcoma
St. Joseph's Hospital and Medical Center, Phoenix 80
Testing effectiveness (Phase 2)Study completedNCT04388475
What this trial is testing

Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma

Who this might be right for
Recurrent Malignant GliomaBrain Glioblastoma
Oblato, Inc. 57
Testing effectiveness (Phase 2)Study completedNCT00616005
What this trial is testing

Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide

Who this might be right for
Glioblastoma
Duke University 41
Early research (Phase 1)Study completedNCT01470794
What this trial is testing

Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaAnaplastic Oligodendroglioma+1 more
Tocagen Inc. 58
Early research (Phase 1)Study completedNCT00005951
What this trial is testing

Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University
Testing effectiveness (Phase 2)Study completedNCT00028795
What this trial is testing

Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Children's Oncology Group 170
Early research (Phase 1)Study completedNCT03387020
What this trial is testing

Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors

Who this might be right for
CNS Embryonal Tumor, Not Otherwise SpecifiedMalignant GliomaRecurrent Atypical Teratoid/Rhabdoid Tumor+4 more
Pediatric Brain Tumor Consortium 22
Testing effectiveness (Phase 2)Ended earlyNCT00387894
What this trial is testing

Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Adult Brain Tumors
Michael Prados 6
Testing effectiveness (Phase 2)Ended earlyNCT00365222
What this trial is testing

Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGliosarcoma
H. Lee Moffitt Cancer Center and Research Institute 1
Testing effectiveness (Phase 2)Ended earlyNCT00068770
What this trial is testing

Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Not applicableNot Yet RecruitingNCT06845020
What this trial is testing

CSF Proteomic Characterization of Glioblastomas

Who this might be right for
GlioblastomaGlioblastoma WHO Grade IVGlioblastoma (GBM)+2 more
Univeridad Autonoma de Guadalajara 15
Not applicableLooking for participantsNCT06283927
What this trial is testing

The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioblastoma, IDH-wildtype+5 more
Jasper Gerritsen 464
Not applicableNot Yet RecruitingNCT07699172
What this trial is testing

EEG-Guided Cognitive Function Preservation in Patients With Brain Tumors

Who this might be right for
GliomaBrain NeoplasmBrain Tumor Adult
Bo Wang 10
Not applicableStudy completedNCT00067418
What this trial is testing

Light Scattering Spectroscopy to Determine Brain Tumors

Who this might be right for
Epilepsy, Temporal LobeTemporal Lobe
National Institute of Neurological Disorders and Stroke (NINDS) 50
Testing effectiveness (Phase 2)Study completedNCT00553150
What this trial is testing

Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
Alliance for Clinical Trials in Oncology 122
Not applicableStudy completedNCT01699269
What this trial is testing

Histopathologic Evaluation of High Grade Brain Tumors by High Order Diffusion Tensor Imaging

Who this might be right for
High Grade Brain Tumor
University Hospital, Clermont-Ferrand 10
Early research (Phase 1)Study completedNCT00612651
What this trial is testing

PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas

Who this might be right for
GliosarcomaGlioblastomaAnaplastic Astrocytoma
Duke University 37
Post-approval studies (Phase 4)Ended earlyNCT01756729
What this trial is testing

Post-approval Study of NovoTTF-100A in Recurrent GBM Patients

Who this might be right for
Recurrent Glioblastoma Multiforme
NovoCure Ltd. 13
Not applicableUnknownNCT04488783
What this trial is testing

Potentiation of Chemotherapy in Brain Tumors by Zinc

Who this might be right for
Newly Diagnosed Glioblastoma Who Underwent at Least Partial Resection of the Tumor Surgically
Sheba Medical Center 30
Early research (Phase 1)Study completedNCT00080054
What this trial is testing

Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas

Who this might be right for
GliomaGlioblastomaAstrocytoma+2 more
Pharmacyclics LLC. 24
Next Page